Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AXS Vecta 46 Intermediate Catheter

K-Number: K202752 · 2021-08-27

Decision Date2021-08-27
Product CodeQJP
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

AXS Vecta 46 Intermediate Catheter is a medical device manufactured by Stryker Neurovascular. It received FDA 510(k) clearance on 2021-08-27 under approval number K202752. The device is classified under product code QJP. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AXS Vecta 46 Intermediate Catheter?

AXS Vecta 46 Intermediate Catheter is a medical device that received FDA 510(k) clearance on 2021-08-27. It is manufactured by Stryker Neurovascular. The 510(k) number is K202752.

When was AXS Vecta 46 Intermediate Catheter approved by the FDA?

AXS Vecta 46 Intermediate Catheter received FDA 510(k) clearance on 2021-08-27, under approval number K202752.

What company makes AXS Vecta 46 Intermediate Catheter?

AXS Vecta 46 Intermediate Catheter is manufactured by Stryker Neurovascular.

What is the FDA product code for AXS Vecta 46 Intermediate Catheter?

The FDA product code for AXS Vecta 46 Intermediate Catheter is QJP.

Related Clinical Trials

Other Devices by Stryker Neurovascular

View all 26 devices →

Related Devices (Code: QJP)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.